Propofol Injection Pain Anaesthesia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients aged 18 to 65 years ASA physical status 1 and 2
Exclusion criteria
Exclusion criteria: Systemic Arterial Hypertension. Pregnancy. History of or active phlebitis/thrombophlebitis. Allergy or hypersensitivity (asthma, rhinitis, angioedema or urticaria) to lornoxicam and any of its excipients. Presence of any contraindication to NSAID use and particularly: Renal disease/renal impairment Hypersensitivity to any other NSAIDs Documented thrombocytopenia Gastro-intestinal bleeding, cerebrovascular bleeding or other bleeding disorders History of gastrointestinal bleeding or perforation, related to previous NSAIDs therapy Active or history of recurrent peptic ulcer/haemorrhage Severe hepatic impairment Severe heart failure. Patients already on other NSAID therapy. Language barriers in eexplaining study plan and obtaining consent. Difficult venous access (more than 2 attempts and/or <G20 cannula) Patients presenting for emergency surgery. Patients in pain. ASA physical status 3 and 4.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity of propofol injection pain. | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of propofol injection pain | — |
Countries
Kenya
Contacts
Anaesthesiology Resident